Protara Therapeutics (NASDAQ:TARA – Get Rating) and Surrozen (NASDAQ:SRZN – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current ratings and […]
NEW YORK (AP) NEW YORK (AP) Protara Therapeutics, Inc. (TARA) on Wednesday reported a loss of $39 million in its fourth quarter. On a per-share basis, the New York-based company said it had a loss of $3.46.
/PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical-stage biopharmaceutical company dedicated to developing precise cancer therapeutics, today.